MedTrace Logo

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

NCT07564726 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2026-05-08

No results posted yet for this study

Summary

The goal of this clinical trial is to test whether one pill that combines ezetimibe, rosuvastatin, and amlodipine can safely lower cholesterol and blood pressure in Korean adults with high blood pressure and high cholesterol.

Conditions

Interventions

DRUG

Amlodipine

Oral tablet containing amlodipine 10 mg administered for 8 weeks.

DRUG

Ezetimibe/Rosuvastatin

Fixed-dose combination oral tablet containing ezetimibe 10 mg and rosuvastatin 20 mg administered for 8 weeks.

DRUG

Ezetimibe/Rosuvastatin Placebo

Placebo for ezetimibe/rosuvastatin (10mg/20mg)

DRUG

Amlodipine Placebo

Placebo for amlodipine (10mg)

Sponsors & Collaborators

  • Celltrion Pharm, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-05
Primary Completion
2024-02-13
Completion
2024-02-13

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07564726 on ClinicalTrials.gov